NBE Declares Result of the Second Round of Counseling for Sponsored DNB (Post MBBS) seats

Published On 2022-12-01 09:00 GMT   |   Update On 2022-12-01 09:00 GMT

New Delhi : Through a recent notice, NBE (National Board of Examination) has released Allotment result of the Second Round of Counseling for Sponsored DNB (Post MBBS) seats 2022 admission session.As per the notified schedule, the Result of Second Round of Counseling for Sponsored DNB (Post MBBS) seats for 2022 admission session has been declared and is available at...

Login or Register to read the full article

New Delhi : Through a recent notice, NBE (National Board of Examination) has released Allotment result of the Second Round of Counseling for Sponsored DNB (Post MBBS) seats 2022 admission session.

As per the notified schedule, the Result of Second Round of Counseling for Sponsored DNB (Post MBBS) seats for 2022 admission session has been declared and is available at website: http://counseling.nbe.edu.in/

Click here to view the allotment result of Round-1

 The details of the payment of the First-year course fee and Physical joining can be seen in the Public Notice dated: 03.11.2022. Failing to make payment for the allotted Sponsored seat in the stipulated time, shall lead to CANCELLATION of the allotted seat.

Candidates are requested to join their DNB training at the allotted institute on or before 07.12.2022. No relaxation in the physical joining shall be permissible beyond 07.12.2022 (1600 hrs.). Candidates who do not join their allotted institute by 07.12.2022 will lose their Sponsored DNB (Post MBBS) seat & their Fee shall be forfeited. 

To view the official Notice, Click here : https://medicaldialogues.in/pdf_upload/natboard-datapublicnoticenotice202212012166-192674.pdf


Tags:    

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News